Description
This comprehensive panel is designed to diagnose and characterize acute leukemia, a rapidly progressing blood cancer. It includes a range of tests that examine blood and bone marrow samples for specific genetic markers, cell surface antigens, and other molecular features. The panel helps differentiate between acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL), as well as identify specific subtypes. Results from this panel are crucial for determining the most effective treatment approach, predicting prognosis, and monitoring response to therapy.
Reviews
There are no reviews yet.